Matrix metalloprotease polymorphisms are associated with gas transfer in alpha 1 antitrypsin deficiency

Therapeutic Advances in Respiratory Disease

Volumn 3, Issue 1, 2009, Pages 23-30

  McAloon, Christopher J ^a   Wood, Alice M ^b   Gough, Stephen C ^b   Stockley, Robert A ^b  

^a UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

alpha 1 antitrypsin; chronic obstructive pulmonary disease; genotyping; matrix metalloproteinase

Indexed keywords

ALPHA 1 ANTITRYPSIN; INTERSTITIAL COLLAGENASE; MACROPHAGE ELASTASE; MATRIX METALLOPROTEINASE; STROMELYSIN;

ADULT; ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DNA POLYMORPHISM; EMPHYSEMA; FEMALE; FORCED EXPIRATORY VOLUME; GAS TRANSPORT; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE MAP; HETEROZYGOTE; HOMOZYGOSITY; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ALLELES; ALPHA 1-ANTITRYPSIN DEFICIENCY; DNA; FEMALE; FORCED EXPIRATORY VOLUME; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 12; MATRIX METALLOPROTEINASE 3; MIDDLE AGED; OXYGEN CONSUMPTION; POLYMORPHISM, GENETIC; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 63049100304     PISSN: 17534658     EISSN: None     Source Type: Journal    
DOI: 10.1177/1753465809102263     Document Type: Article

References (44)

1. ATS (1996) Cigarette smoking and health, Am J Resp Crit Care Med 153: 861-865.
2. Barrett, J.C., Fry, B., Maller, J. and Daly, M.J. (2005) Haploview: analysis and visualization of LD and haplotype maps, Bioinformatics 21(2): 263-265.
3. Belvisi, M.G. and Bottomley, K.M. (2003) The role of matrix metalloproteinases (MMPs) in the pathophysiology of chronic obstructive pulmonary disease (COPD): a therapeutic role for inhibitors of MMPs? Inflamm Res 52: 95-100.
4. Betsuyaku, T., Nishimura, M., Takeyabu, K., Tanino, M., Venge, P., Xu, S. et al. (1999) Neutrophil granule proteins in bronchoalveolar lavage fluid from subjects with subclinical emphysema, Am J Respir Crit Care Med 159: 1985-1991.
5. Bruce, C. and Thomas, P.S. (2005) The effect of marimastat, a metalloprotease inhibitor, on allergen-induced asthmatic hyper-reactivity, Toxicol Appl Pharmacol 205: 126-132.
6. Churg, A., Wang, X., Wang, R.D., Meixner, S.C., Pryzdial, E.L. and Wright, J.L. (2007) Alpha-1-antitrypsin suppresses TNF-alpha and MMP-12 production by cigarette smoke-stimulated macrophages, Am J Respir Cell Mol Biol 37: 144-151.
7. D'Armiento, J., Dalal, S.S., Okada, Y., Berg, R.A. and Chada, K. (1992) Collagenase expression in the lungs of transgenic mice causes pulmonary emphysema, Cell 71: 955-961.
8. Decramer, M., Rutten-van Molken, M., Dekhuijzen, P.N., Troosters, T., van Herwaarden, C., Pellegrino, R. et al. (2005) Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial, Lancet 365: 1552-1560.
9. DeMeo, D.L., Campbell, E.J., Barker, A.F., Brantly, M.L., Eden, E., McElvaney, N.G. et al. (2008) IL10 polymorphisms are associated with airflow obstruction in severe alpha1-antitrypsin deficiency, Am J Respir Cell Mol Biol 38: 114-120.
10. DeMeo, D.L., Hersh, C.P., Hoffman, E.A., Litonjua, A.A., Lazarus, R., Sparrow, D. et al. (2007) Genetic determinants of emphysema distribution in the national emphysema treatment trial, Am J Respir Crit Care Med 176: 42-48.
11. DeMeo, D.L. and Silverman, E.K. (2004) Alpha-1-antitrypsin deficency: phenotypes and genetic modifers of emphysema risk, Thorax 59: 259-264.
12. Dowson, L.J., Guest, P.J., Hill, S.L., Holder, R.L. and Stockley, R.A. (2001) High-resolution computed tomography scanning in alpha1-antitrypsin deficiency: relationship to lung function and health status, Eur Respir J 17: 1097-1104.
13. Elston, R.C. and Ann Spence, M. (2006) Advances in statistical human genetics over the last 25 years, Statist Med 25: 3049-3080.
14. Finlay, G.A., Russell, K.J., McMahon, M., D’ Arcy, E., Masterson, J.B., FitzGerald, M.X. et al. (1997) Elevated levels of matrix metalloproteinases in bronchoalveolar lavage fluid of emphysematous patients, Thorax 52: 502-506.
15. Fletcher, C. and Peto, R. (1977) The natural history of chronic airflow obstruction, Br Med 1(6077): 1645-1648.
16. Golub, L.M., Lee, H.M., Ryan, M.E., Giannobile, W.V., Payne, J. and Sorsa, T. (1998) Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms, Adv Dent Res 12: 12-26.
17. Gottlieb, D.J., Sparrow, D., Gale, M.E., Weiss, S.T., Snider, G.L. and O'Conner, G.T. (1996) Urinary desmosine excretion in smokers with and without rapid decline of lung function: the normal aging study, Am J Resp Crit Care Med 154: 1290-1295.
18. Harel, S., Janoff, A., Yu, S.Y., Hurewitz, A. and Bergofsky, E.H. (1980) Desmosine radioimmunoassay for measuring elastin degradation in vitro, Rev Respir Dis 122: 769-773.
19. Hautamaki, R.D., Kobayashi, D.K., Senior, R.M. and Shapiro, S.D. (1997) Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice, Science 277: 2002-2004.
20. Hersh, C.P., Demeo, D.L., Lange, C., Litonjua, A.A., Reilly, J.J., Kwiatkowski, D. et al. (2005) Attempted replication of reported chronic obstructive pulmonary disease candidate gene associations, Am J Respir Cell Mol Biol 33: 71-78.
21. Hill, A.T., Campbell, E.J., Bayley, D.L., Hill, S.L. and Stockley, R.A. (1999) Evidence for excessive bronchial inflammation during an acute exacerbation of chronic obstructive pulmonary disease in patients with alpha(1)-antitrypsin deficiency (PiZ), Am J Respir Crit Care Med 160: 1968-1975.
22. Holme, J., Stockley, J.A. and Stockley, R.A. (2007) When should we start monitoring alpha 1 antitrypsin deficient subjects? Thorax 62: A140.
23. Holme, J. and Stockley, R.A. (2007) Radiologic and clinical features of COPD patients with discordant pulmonary physiology: lessons from alpha1-antitrypsin deficiency, Chest 132: 909-915.
24. International HapMap Consortium (2005) A haplotype map of the human genome, Nature 437: 1299-1320.
25. Joos, L., He, J.Q., Shepherdson, M.B., Connett, J.E., Anthonisen, N.R., Pare, P.D. et al. (2002) The role of matrix metalloproteinase polymorphisms in the rate of decline in lung function, Hum Mol Genet 11: 569-576.
26. Ma, S., Lin, Y.Y. and Turino, G.M. (2007) Measurements of desmosine and isodesmosine by mass spectrometry in COPD, Chest 131: 1363-1371.
27. Muller, N.L., Staples, C.A., Miller, R.R. and Abboud, R.T. (1988) ’Density mask’. An objective method to quantitate emphysema using computed tomography, Chest 94: 782-787.
28. Nagase, H. and Woessner, J. (1999) Matrix metalloproteinases, J Bio Chem 274: 21491-21494.
29. Needham, M. and Stockley, R.A. (2004) Alpha-1-antitrypsin deficiency: clinical manifestations and natural history, Thorax 59: 441-445.
30. Newby, P.R., Roberts-Davies, E.L., Brand, O.J., Heward, J.M., Franklyn, J.A., Gough, S.C. et al. (2007) Tag SNP screening of the PDCD1 gene for association with Graves’ disease, Clin Endocrinol (Oxf) 67: 125-128.
31. Parr, D.G., Stoel, B.C., Stolk, J. and Stockley, R.A. (2004) Pattern of emphysema distribution in alpha1-antitrypsin deficiency influences lung function impairment, Am J Respir Crit Care Med 170(11): 1172-1178.
32. Pendas, A.M., Santamaria, I., Alvarez, M.V., Pritchard, M. and Lopez-Otin, C. (1996) Fine physical mapping of the human matrix metalloproteinase genes clustered 11q22.3, Genomics 37: 266-282.
33. Rennard, S.I., Fogarty, C., Kelsen, S., Long, W., Ramsdell, J., Allison, J. et al. (2007) The safety and efficacy of infliximab in moderate to severe chronic obstructive pulmonary disease, Am J Respir Crit Care Med 175: 926-934.
34. Rutter, J.L., Mitchell, T.I., Buttice, G., Meyers, J., Gusella, J.F., Ozelius, L.J. et al. (1998) A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription, Cancer Res 58: 5321-5325.
35. Seitz, M., Wirthmuller, U., Moller, B. and Villiger, P.M. (2007) The -308 tumour necrosis factor-alpha gene polymorphism predicts therapeutic response to TNFalpha-blockers in rheumatoid arthritis and spondyloarthritis patients, Rheumatology (Oxford) 46: 93-96.
36. Soejima, K., Yamaguchi, K., Kohda, E., Takeshita, K., Ito, Y., Mastubara, H. et al. (2000) Longitudinal follow-up study of smoking-induced lung density changes by high-resolution computed tomography, Am J Respir Crit Care Med 161: 1264-1273.
37. Stockley, R.A. (1999) Neutrophils and protease/ antiprotease imbalance, Am J Respir Crit Care Med 160: S49-52.
38. Stockley, R.A. and Luisetti, M. (eds) (1999) Alpha-1-Antitrypsin Deficiency: The Biochemical Basis of Pulmonary Emphysema. Pavia: IRCCS.
39. Stolk, J. (2007) Identification of genetic modifiers of emphysema in phenotypically discordant PiZZ alpha 1 antitrypsin deficient patients. Personal communication, ERS, Stockholm.
40. Tsukahara, S., Shinozaki, M., Ikari, K., Mochizuki, T., Inoue, E., Tomatsu, T. et al. (2008) Effect of matrix metalloproteinase-3 functional SNP on serum matrix metalloproteinase-3 level and outcome measures in Japanese RA patients, Rheumatology (Oxford) 47: 41-44.
41. Wood, A.M., McNab, G.L. and Stockley, R.A. (2007a) A polymorphism in the matrix metalloproteinase 9 gene may influence emphysema distribution in alpha 1 anti-trypsin deficiency, British Thoracic Society London 62: A115.
42. Wood, A.M., Simmonds, M.J., Newby, P.R., Gough, S.C. and Stockley, R.A. (2007b) Variation in the surfactant protein B gene is associated with development of airflow obstruction in alpha 1 anti-trypsin deficiency, British Thoracic Society London 62: A29.
43. Wood, A.M. and Stockley, R.A. (2006) The genetics of chronic obstructive pulmonary disease, Respir Res 7: 130.
44. Wtccc (2007) Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls, Nature 447: 661-678.